Tyra Biosciences (TYRA) Non Operating Income (2020 - 2026)

Tyra Biosciences' Non Operating Income history runs 7 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• Quarterly Non Operating Income fell 27.28% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.8 million (down 31.74% YoY) and the FY2025 annual result came in at $12.8 million, down 27.58% from the prior year.
• Non Operating Income was $2.7 million for Q1 2026 at Tyra Biosciences, roughly flat from $2.7 million in the prior quarter.
• Across five years, Non Operating Income topped out at $4.8 million in Q2 2024 and bottomed at $8000.0 in Q1 2022.
• A 5-year average of $2.8 million and a median of $2.8 million in 2023 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2022 — Non Operating Income surged 106050.0% — and 2025, when it sank 35.73%.
• Tyra Biosciences' Non Operating Income stood at $2.1 million in 2022, then soared by 32.08% to $2.8 million in 2023, then soared by 48.82% to $4.2 million in 2024, then sank by 35.73% to $2.7 million in 2025, then rose by 0.41% to $2.7 million in 2026.
• Business Quant data shows TYRA's Non Operating Income at $2.7 million in Q1 2026, $2.7 million in Q4 2025, and $3.1 million in Q3 2025.